A multinational, preregistered cohort study of β-lactam/β- lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae

Category Primary study
JournalAntimicrobial Agents Chemother
Year 2016
This article has no abstract
Epistemonikos ID: 4d4e60f9f9826232b0e2782d352b275ce6be0699
First added on: May 28, 2018